Trial · NCT07885852
Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD)
NCT07885852, Not applicable, Not yet recruiting, University Hospital Virgen de las Nieves
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD). Trials, record NCT07885852. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885852
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD)
- NCT number
- NCT07885852
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 250 participants, estimated
- Lead sponsor
- University Hospital Virgen de las Nieves
- Conditions
- Post ERCP Pancreatitis, Acute Pancreatitis (AP)
- Interventions
- Cold water irrigation of the papilla, Rectal NSAID (diclofenac 100 mg)
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of post-ERCP pancreatitis (Cotton criteria) | Day 1 | Clinical and analytical pancreatitis within 24 hours after inclusion in the study. |
| Secondary | Severity of post-ERCP pancreatitis (revised Atlanta classification) | Up to 14 days | In cases with acute pancreatitis, adequate grading of severity is performed 14 days after inclusion in the study, which is the minimum time frame for a complete Atlanta Classification. |
| Secondary | Incidence of post-ERCP pancreatitis in patients with difficult cannulation and with pancreatic duct cannulation | Day 1 | Clinical and analytical pancreatitis within 24 hours after inclusion in the study, in cases with difficult cannulation. |
| Secondary | Incidence of post-ERCP pancreatitis according to use of aggressive hydration or pancreatic stent | Day 1 | Clinical and analytical pancreatitis within 24 hours after inclusion in the study, in cases with additional preventive measures. |
| Secondary | Adverse events (bleeding, perforation, cholangitis, other) | Up to 7 days | Occurrence of other ERCP adverse events. |
| Secondary | Length of hospital stay | Up to 30 days | Days admitted from the inclusion in the study to hospital discharge. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885852
GET https://conductscience.org/api/trials/v1/NCT07885852/registered